Onyx Biotec Limited IPO

Onyx Biotec Ltd

₹1,16,000 /2000 sharesMinimum Investment

Onyx Biotec Limited IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
13 Nov ‘24 - 18 Nov ‘24₹1,16,0002,000₹58 - ₹61
Issue SizeIPO Doc
29.34Cr
RHP PDF

Subscription rate

As of 13 Nov'24, 06:00 PM
Qualified Institutional Buyers0x
Non-Institutional Investor0x
Retail Individual Investor0x
Total2.80313588850174x

About Onyx Biotec Limited

Onyx Biotec Limited is a pharmaceutical company specialising in the production of sterile pharmaceutical products such as sterile water for injections, dry powder injections, and dry syrups. Onyx serves as a contract manufacturer, providing comprehensive product development and manufacturing solutions for clients in India and overseas. The company operates two World Health Organisation’s good manufacturing practices (WHO-GMP)-certified manufacturing facilities in Himachal Pradesh, India.;
Founded in
2005
Managing director
Mr. Sanjay Jain
Parent organisation
Onyx Biotec Ltd

Strengths & Financials of Onyx Biotec Limited

Strengths
Risks
Onyx Biotec has over a decade of experience in sterile pharmaceutical manufacturing. The company has built a strong reputation among leading Indian and multinational pharmaceutical companies.
The company operates two manufacturing units in Himachal Pradesh, a major pharmaceutical hub, benefiting from access to skilled labour and cost-effective operations.
Onyx Biotec is ISO 9001:2015 certified for quality management systems and ISO 14001:2015 certified for environmental management systems.
The company claims to have a client base of over 100 pharmaceutical companies, with repeat business from 35 clients in recent years.
Onyx Biotec’s manufacturing facilities are WHO-GMP certified. Regular audits and inspections by clients and regulatory bodies are conducted to ensure continued compliance and uphold production quality.

Onyx Biotec Limited Financials

*All values are in Rs. Cr
No Graph Data To Display

Application Details of Onyx Biotec Limited IPO

Apply asPrice bandApply upto
Regular58 - 61₹2 Lakh
High Networth Individual58 - 61₹2 - 5 Lakh
For Onyx Biotec Limited IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW